| Name | Methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate |
|---|---|
| Synonyms |
5-Pyrimidinecarboxylic acid, 2,4-dichloro-6-methyl-, methyl ester
Methyl 2,4-dichloro-6-methyl-5-pyrimidinecarboxylate methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 292.3±35.0 °C at 760 mmHg |
| Molecular Formula | C7H6Cl2N2O2 |
| Molecular Weight | 221.041 |
| Flash Point | 130.6±25.9 °C |
| Exact Mass | 219.980637 |
| PSA | 52.08000 |
| LogP | 1.82 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.547 |
| HS Code | 2933599090 |
|---|
|
~77%
36745-93-4 |
| Literature: Takeda Pharmaceutical Company Limited Patent: US2011/152273 A1, 2011 ; Location in patent: Page/Page column 28 ; |
|
~%
36745-93-4 |
| Literature: GRÜNENTHAL GMBH; LUCAS, Simon; Kühnert, Sven; Bahrenberg, Gregor; Schröder, Wolfgang Patent: US2014/148454 A1, 2014 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |